Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...

Learn more about whether The Ensign Group, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Private equity firm KKR increased its stake in Henry Schein Inc., investing $250 million in the company to help boost financial performance, according to the Melville-based company. The investment ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

And SiriusXM host Adam Schein was none too happy about it. NFL officiating has become an unfortunate storyline through yet another run to the Super Bowl for the Kansas City Chiefs thanks to a ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.